JPRN-UMIN000003197已完成3 期
A Phase III Study Comparing Methotrexate, Adrimycin and Cisplatin (MAP) with MAP + Ifosfamide (MAP + IF) for the Treatment of Osteosarcoma (JCOG0905/OS-MAP + IF-P3) - A Phase III Study Comparing Methotrexate, Adrimycin and Cisplatin (MAP) with MAP + Ifosfamide (MAP + IF) for the Treatment of Osteosarcoma (JCOG0905/OS-MAP + IF-P3)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 250 人开始时间: 2010年2月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 250
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 50years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Uncontrollable diabetes mellitus. 2) Uncontrollable hypertension. 3) History of myocardial infarction or attack of unstable angina pectoris. 4) Artificial pacemaker. 5) Active bacterial or fungous infection. 6) Fever over 38 degrees centigrade. 7) Simultaneous or metachronous (within the past 5 years) double cancers. 8) Women during pregnancy or breast-feeding. 9) Women within 28 days after delivery or women 29 days or more after delivery without uterine subinvolution confirmed by an obstetrician. 10) Psychosis. 11) Systemic steroids medication. 12) Positive for HBs antigen, HBc antibody, or HBs antibody.
研究者
相似试验
已完成
不适用
Comparison of Actinomycin D and Methotrexate in treatment of Mole HydatiformGestational Trophoblastic Neoplasia.Mole Hydatiform,Nonspecific Trophoblastic Disease NOSIRCT2012062810128N1Jundishapur Medical Science University Branch of Research30
进行中（未招募）
3 期
JCOG0905:A Phase III Study Comparing Methotrexate, Adrimycin and Cisplatin (MAP) with MAP + Ifosfamide (MAP + IF) for the Treatment of OsteosarcomaHigh grade osteosarcoma, TNM stage II-IIIJPRN-jRCTs031180126HIRAGA Hiroaki250
尚未招募
4 期
Comparison of the effectiveness of two medicines namely Methotrexate and Apremilast in patients with a skin disease called psoriasisCTRI/2019/04/018854Yenepoya Medical College
已完成
3 期
Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic NeoplasiaFIGO Stage I Gestational Trophoblastic TumorFIGO Stage II Gestational Trophoblastic TumorFIGO Stage III Gestational Trophoblastic TumorChoriocarcinomaHydatidiform MoleNCT01535053GOG Foundation57
尚未招募
不适用
To compare the effect of three drugs- methotrexate, apremilast and their combination in patients suffering from psoriasis vulgaris.CTRI/2019/07/020274Department of Dermatology